Among the potential MGL ligands, we identified glycoproteins that are linked to ovarian cancer progression, such as IGFBP7, MUC16, and VCAN, suggesting that MGL expressed by DCs may exert its immunoregulatory role by interacting with distinct cellular and matrix components. This evidence concerns the gene CLEC10A and ovarian carcinoma.